Updates are available Correction dated 2025-12-05
Click to view Correction: https://doi.org/10.1007/s11096-025-02068-x
-
Authors
Hartinger, Jan Miroslav
Tašková, Ivana
Gregorová, Jana
Slanař, Ondřej
Fialová, Daniela
- License Information
-
More Information
Article History
Received: 30 June 2025
Accepted: 26 August 2025
First Online: 30 September 2025
Change Date: 5 December 2025
Change Type: Update
Change Details: The original online version of this article was revised: References 34, 36, 37, 38, and their corresponding in-text citations, were removed during the editorial review.
Change Date: 5 December 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s11096-025-02068-x
Declarations
:
: JH and JG are members of the general committee of Czech Professional Society of Clinical Pharmacy and therefore were involved in national CP policy. DF is a chair of the “Ageing, Polypharmacy and Changes in the Therapeutic Value of Drugs in the AgeD” Research Unit and was a leader for the Czech research team of projects stated in Table 5. The authors state that they have no other competing interests regarding this article.
: Not required.
